Cite
HARVARD Citation
Geretti, A. et al. (2019). Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance. Journal of antimicrobial chemotherapy. pp. 746-753. [Online].